biotech
PTx picks up radiation drug and plant from Sanofi
February 6, 2018Manufacturing and Production, Sales and Marketing Partnership Therapeutics, Sanofi, biotech, drugs, pharma, pharmaceutical
A Boston-based biotech, only a few weeks old, has moved quickly to secure both the drug Leukine and the plant …
Two former Greek PMs implicated in Novartis bribery case
February 6, 2018Manufacturing and Production, Medical Communications Greece, Novartis, biotech, drugs, pharma, pharmaceutical
An ongoing investigated case into Novartis sales practices in Greece has so far implicated 10 current and former politicians. The …
Incidence of strokes in younger people rising
February 1, 2018Medical Communications biotech, drugs, pharma, pharmaceutical, stroke
On the day that a new campaign for greater awareness of stroke symptoms has been released, new figures show that …
NICE approves Perjeta for routine use on NHS
February 1, 2018Sales and Marketing Perjeta, Roche, biotech, drugs, pharma, pharmaceutical
NICE has given the nod to Roche’s Perjeta for routine first-line use, alongside Herceptin and chemotherapy, in patients with HER2-positive …
New blood test for Alzheimer’s offers hope
February 1, 2018Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
To say January was a bleak month for Alzheimer’s research would be something of an understatement: Pfizer ducked out of …
Seattle in $614m move for Cascadian Therapeutics
January 31, 2018Sales and Marketing Cascadian Theapeutics, HER2, Seattle Genetics, biotech, drugs, pharma, pharmaceutical
Things don’t always go quite according to plan in the biotech world – something both Seattle Genetics and Cascadian Therapeutics …
Ipsen promotes new CMO from within
January 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical
Ipsen has announced that Sotirios G. Stergiopoulos will become its newest Chief Medical Officer, performing the role alongside his current …
NHS Digital lambasted for collusion with Home Office to deport migrants
January 31, 2018Medical Communications, Research and Development NHS Digital, biotech, drugs, immigration, pharma, pharmaceutical
NHS Digital, the Department of Health and the Home Office have been strongly criticised for entering a memorandum of understanding …
Amazon makes first steps into healthcare, alongside big partners
January 31, 2018Medical Communications, Research and Development Berkshire Hathaway, JPMorgan, amazon, biotech, drugs, pharma, pharmaceutical
Amazon’s move into the healthcare sector has been widely mooted over the last 12 months and it officially announced that …
Italy refuses to give up hope on EMA HQ
January 30, 2018Medical Communications, Research and Development EMA, amsterdam, biotech, drugs, pharma, pharmaceutical
It is no secret that Milan was not best pleased that it was pipped to the post to host the …
FDA revises methods, after public outrage at testing of monkeys
January 29, 2018Manufacturing and Production, Medical Communications FDA, biotech, drugs, pharma, pharmaceutical
The story broke in September of last year that the FDA was testing nicotine addiction in squirrel monkeys and that …
Delivering the life sciences agenda: Easy as ABC
January 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life sciences strategy, biotech, brexit, drugs, pharma, pharmaceutical
Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical Campus …
Radioactive drug given approval by the FDA
January 29, 2018Sales and Marketing Advanced Accelerator Applications, Lutathera, Novartis, biotech, drugs, pharma, pharmaceutical
The FDA has approved Lutathera, marking the first time that the agency has given approval for a radioactive drug or …
Brexit Health Alliance warns of UK at back of the medicine queue
January 29, 2018Medical Communications, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical
The Brexit Health Alliance (BHA) has cautioned that unless a favourable deal is struck, the UK could end Brexit negotiations …
Sanofi swoops for Ablynx in $4.8bn deal
January 29, 2018Sales and Marketing Ablynx, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi has moved quickly to tie up a deal with Ablynx for $4.8 billion, when it looked more likely that …
Latest content
